Work

HER2 extracellular domain (ECD) and HER2 single nucleotide polymorphisms (SNPs) in patients treated with combination trastuzumab, lapatinib, and bevacizumab.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.e22082

Authors: Mei Huang, Kristin L. Parkhurst, Yunfang Jiang, Stacy L. Moulder, Aung Naing, Jennifer J. Wheler, David S. Hong, Sarina Anne Piha-Paul, Siqing Fu, Apostolia Maria Tsimberidou, Ralph Zinner, Filip Janku, Razelle Kurzrock, Gerald Steven Falchook

Institutions: The University of Texas MD Anderson Cancer Center, University of California San Diego, Moores Cancer Center

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2603522483

Cites:

Cited by:

Related to: 10